TrialStroke2012

Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy.

Jacques E Rossouw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.